Painless Jaundice and a Palpable Gallbladder
A 58-year-old woman presents with a three-month history of progressive painless jaundice, pruritus, dark urine, and pale stools. She has lost 8 kg unintentionally. She denies fever, abdominal pain, or previous gallstones. Examination reveals scleral icterus and a smooth, non-tender, palpable mass in the right upper quadrant below the liver edge. Laboratories show total bilirubin 12.4 mg/dL with direct bilirubin 9.1 mg/dL, alkaline phosphatase 620 U/L, ALT 85 U/L, amylase 70 U/L, and CA 19-9 450 U/mL. Ultrasound demonstrates dilated intrahepatic and extrahepatic bile ducts, a distended gallbladder, and a 3-cm hypoechoic mass in the pancreatic head. There is no gallstone or biliary sludge. You are asked to explain the mechanism of the jaundice and palpable gallbladder, and to predict the microscopic findings at the obstruction site.
1. Explain the mechanism of jaundice and the palpable gallbladder in this patient.
Read the worked answer
The pancreatic head mass obstructs the distal common bile duct, producing conjugated hyperbilirubinemia. Conjugated bilirubin is water-soluble, so it appears in urine (dark urine), while bile cannot reach the intestine, causing pale stools and steatorrhea; retained bile salts cause pruritus. Alkaline phosphatase rises because cholestasis induces enzyme synthesis in bile duct epithelium. The gallbladder becomes palpable because obstruction is distal to the cystic duct and the gallbladder wall is not chronically fibrotic or contracted from repeated stone disease. This is Courvoisier sign: a non-tender, distended gallbladder in a jaundiced patient is suspicious for malignant obstruction rather than stones. The absence of fever and pain also argues against acute cholecystitis.
2. Predict the histologic features of the obstructing lesion and explain why CA 19-9 is not diagnostic.
Read the worked answer
The histology is likely pancreatic ductal adenocarcinoma: atypical glands infiltrating a desmoplastic stroma, nuclear pleomorphism, and perineural or lymphovascular invasion. The mass is hypoechoic and located in the pancreatic head, the usual site. CA 19-9 is not diagnostic because it is a carbohydrate antigen that can rise in cholestasis, pancreatitis, and other gastrointestinal cancers; 5–10% of people are Lewis-negative and cannot produce it. Here the marked bilirubin elevation can itself raise CA 19-9. The test is best used for prognosis and monitoring after a tissue diagnosis, not to confirm cancer. Tissue is usually obtained by endoscopic ultrasound-guided fine-needle aspiration if the result will change management.
3. Which nearby structures are likely invaded, and what clinical symptom might that cause?
Read the worked answer
The tumor may invade the superior mesenteric artery or vein, portal vein, duodenum, and peripancreatic neural plexuses. Celiac plexus invasion is common and produces boring, gnawing back pain that may be relieved by leaning forward. Duodenal invasion can cause gastric outlet obstruction, vomiting, and occult bleeding. Portal vein or superior mesenteric vein encasement may cause varices or ascites and often makes resection impossible. These anatomic relationships explain why only a minority of pancreatic head cancers are resectable at diagnosis and why staging with vascular imaging is essential.